Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2014 | 04-2014 | 01-2014 | 10-2013 | 07-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 401 | 151 | 207 | 269 | 227 |
| Marketable Securities | 3,187 | 3,704 | 4,132 | 4,614 | 4,840 |
| Receivables | 94 | 94 | 35 | 50 | 53 |
| TOTAL | $3,701 | $3,965 | $4,413 | $5,061 | $5,263 |
| Non-Current Assets | |||||
| PPE Net | 15 | 16 | 17 | 19 | 5 |
| Intangibles | 599 | 663 | 850 | 1,046 | 1,204 |
| TOTAL | $614 | $679 | $867 | $1,065 | $1,208 |
| Total Assets | $4,315 | $4,644 | $5,280 | $6,126 | $6,471 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 207 | 165 | 176 | 221 | 124 |
| TOTAL | $207 | $165 | $176 | $221 | $124 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $207 | $165 | $176 | $221 | $124 |
| Shareholders' Equity | |||||
| Common Shares | 24,716 | 23,980 | 24,649 | 25,820 | 25,530 |
| Retained earnings | -24,152 | -22,973 | -23,082 | -23,596 | -22,810 |
| Other shareholders' equity | 854 | 836 | 871 | 913 | 902 |
| TOTAL | $4,108 | $4,479 | $5,103 | $5,906 | $6,347 |
| Total Liabilities And Equity | $4,315 | $4,644 | $5,280 | $6,126 | $6,471 |